Mutation burden profile in familial Alzheimer's disease cases from India

[1]  Shirley A. Miller,et al.  A simple salting out procedure for extracting DNA from human nucleated cells. , 1988, Nucleic acids research.

[2]  J. Morris.  The Clinical Dementia Rating (CDR) , 1993, Neurology.

[3]  M. Mega,et al.  The Neuropsychiatric Inventory , 1994, Neurology.

[4]  Steven H. Belle,et al.  A hindi version of the MMSE: The development of a cognitive screening instrument for a largely illiterate rural elderly population in india , 1995 .

[5]  B. Dubois,et al.  Early-onset autosomal dominant Alzheimer disease: prevalence, genetic heterogeneity, and mutation spectrum. , 1999, American journal of human genetics.

[6]  G. Fillenbaum,et al.  Development of an activities of daily living scale to screen for dementia in an illiterate rural older population in India. , 1999, Age and ageing.

[7]  K. Sleegers,et al.  Familial clustering and genetic risk for dementia in a genetically isolated Dutch population. , 2004, Brain : a journal of neurology.

[8]  R. Tanzi,et al.  Twenty Years of the Alzheimer’s Disease Amyloid Hypothesis: A Genetic Perspective , 2005, Cell.

[9]  Maido Remm,et al.  Enhancements and modifications of primer design program Primer3 , 2007, Bioinform..

[10]  C. Mariani,et al.  Interaction between the APOE ɛ4 allele and the APH-1b c+651T>G SNP in Alzheimer's disease , 2008, Neurobiology of Aging.

[11]  Richard Durbin,et al.  Sequence analysis Fast and accurate short read alignment with Burrows – Wheeler transform , 2009 .

[12]  S. Henikoff,et al.  Predicting the effects of coding non-synonymous variants on protein function using the SIFT algorithm , 2009, Nature Protocols.

[13]  Ken Chen,et al.  VarScan: variant detection in massively parallel sequencing of individual and pooled samples , 2009, Bioinform..

[14]  J. Narayanaswamy,et al.  Is there a familial overlap between dementia and other psychiatric disorders? , 2010, International Psychogeriatrics.

[15]  Sanjeev Jain,et al.  Apolipoprotein E Polymorphism and Dementia: A Hospital-Based Study from Southern India , 2011, Dementia and Geriatric Cognitive Disorders.

[16]  Robert A. Edwards,et al.  Quality control and preprocessing of metagenomic datasets , 2011, Bioinform..

[17]  J. Pariente,et al.  The French series of autosomal dominant early onset Alzheimer's disease cases: mutation spectrum and cerebrospinal fluid biomarkers. , 2012, Journal of Alzheimer's disease : JAD.

[18]  Jennifer Williamson,et al.  Rare Variants in APP, PSEN1 and PSEN2 Increase Risk for AD in Late-Onset Alzheimer's Disease Families , 2012, PloS one.

[19]  I. Adzhubei,et al.  Predicting Functional Effect of Human Missense Mutations Using PolyPhen‐2 , 2013, Current protocols in human genetics.

[20]  K. Jacob.  Dementia assessment: A review of studies from Vellore and perspectives. , 2014, The National medical journal of India.

[21]  Michelle K. Lupton,et al.  Exome sequencing identifies 2 novel presenilin 1 mutations (p.L166V and p.S230R) in British early-onset Alzheimer's disease , 2014, Neurobiology of Aging.

[22]  A. Goate,et al.  Alzheimer’s Disease Risk Genes and Mechanisms of Disease Pathogenesis , 2015, Biological Psychiatry.

[23]  M. Varghese,et al.  Neuropsychological markers of mild cognitive impairment: A clinic based study from urban India , 2015, Annals of Indian Academy of Neurology.

[24]  Jitender Saini,et al.  A study of structural and functional connectivity in early Alzheimer's disease using rest fMRI and diffusion tensor imaging , 2015, International journal of geriatric psychiatry.

[25]  Thomas D. Bird,et al.  Alzheimer Disease Overview , 2015 .

[26]  S. An,et al.  Gene panels and primers for next generation sequencing studies on neurodegenerative disorders , 2015, Molecular & Cellular Toxicology.

[27]  F. Cunningham,et al.  The Ensembl Variant Effect Predictor , 2016, Genome Biology.

[28]  Florian G. Metzger,et al.  Pilot whole-exome sequencing of a German early-onset Alzheimer's disease cohort reveals a substantial frequency of PSEN2 variants , 2016, Neurobiology of Aging.

[29]  Michelle K. Lupton,et al.  Influence of Coding Variability in APP-Aβ Metabolism Genes in Sporadic Alzheimer’s Disease , 2016, PloS one.

[30]  M. Carrillo,et al.  Research priorities to reduce the global burden of dementia by 2025 , 2016, The Lancet Neurology.

[31]  Tsviya Olender,et al.  VarElect: the phenotype-based variation prioritizer of the GeneCards Suite , 2016, BMC Genomics.

[32]  Michael W. Weiner,et al.  Metabolic network failures in Alzheimer's disease: A biochemical road map , 2017, Alzheimer's & Dementia.

[33]  M. Varghese,et al.  Pathways to care among persons with dementia: Study from a tertiary care center. , 2017, Asian journal of psychiatry.

[34]  Nick C Fox,et al.  Rare coding variants in PLCG2, ABI3, and TREM2 implicate microglial-mediated innate immunity in Alzheimer's disease , 2017, Nature Genetics.

[35]  Sanjeev Jain,et al.  Effect of CLU and PICALM polymorphisms on AD risk: A study from south India. , 2017, Asian journal of psychiatry.

[36]  Han Huang,et al.  Functional annotation of Alzheimer's disease associated loci revealed by GWASs , 2017, PloS one.

[37]  The effects of different familial Alzheimer’s disease mutations on APP processing in vivo , 2017, Alzheimer's Research & Therapy.